© 2004 by Oxford University Press
© 2004 Oxford University Press
ARTICLE |
Lymphatic Drainage Imaging of Breast Cancer in Mice by Micro-Magnetic Resonance Lymphangiography Using a Nano-Size Paramagnetic Contrast Agent
Affiliations of authors: Metabolism Branch, Center for Cancer Research (HK, YS, NS, YT, JCM, TAW), Radioimmune and Inorganic Chemistry Section, Radiation Oncology Branch, Center for Cancer Research (MWB), National Cancer Institute, and Diagnostic Radiology Department, Warren G. Magnuson Clinical Center (PLC), Renal Diagnostics and Therapeutics Unit, National Institute of Diabetes and Digestive and Kidney Diseases (RAS), National Institutes of Health, Bethesda, MD; Department of Radiology, School of Medicine, The Johns Hopkins University, Baltimore, MD (SK).
Correspondence to: Hisataka Kobayashi, MD, PhD, Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg. 10, Rm. 4N109, 10 Center Dr., Bethesda, MD 20892-1374 (e-mail: kobayash{at}mail.nih.gov)
Background: The presence of lymph node metastases is an important factor in breast cancer patient prognosis. Therefore, the precise identification of sentinel lymph nodes in these patients is critical. Improving current magnetic resonance (MR) imaging methods using a newly synthesized nano-size paramagnetic molecule, G6, as a contrast agent, provides an attractive means toward attaining this goal. Methods: A four-dimensional method of micro-MR lymphangiography using G6 (9 nm/240 kd) was developed to visualize the lymphatic ducts and lymph nodes draining mouse mammary tumors over time. The ability of micro-MR lymphangiography with the G6 contrast agent to visualize lymphatic drainage of normal mouse mammary tissue was compared with that of the conventional MR contrast agent, Gd-[DTPA]-dimeglumine (<1 kd). Lymphatic drainage in spontaneous and xenografted breast tumor models was visualized using the G6 contrast agent. Results: Draining lymphatic ducts and lymph nodes were clearly visualized in the mammary tissue of normal mice and in spontaneous and xenografted breast tumor models after a direct mammary gland or peritumoral injection of G6. Gd-[DTPA]-dime-glumine, by contrast, failed to depict lymphatic flow from the mammary tissue in normal mice using the same method. Micro-MR lymphangiography using the G6 contrast agent revealed the absence of filling in the metastatic foci of affected lymph nodes. Conclusions: The superior temporal and spatial resolution of micro-MR lymphangiography using the contrast agent G6 may facilitate the study of tumor lymphatic drainage and lymphatic metastasis in both experimental animals and clinical medicine. In addition, this may be a powerful new method for sentinel lymph node localization in human breast cancer.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. E. McNeil Nanotechnology for the biologist J. Leukoc. Biol., September 1, 2005; 78(3): 585 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sugaya, T. Watanabe, A. Yang, M. F. Starost, H. Kobayashi, A. M. Atkins, D. L. Borris, E. A. Hanan, D. Schimel, M. A. Bryant, et al. Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter Blood, March 15, 2005; 105(6): 2356 - 2363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Pathak, D. Artemov, B. D. Ward, D. G. Jackson, M. Neeman, and Z. M. Bhujwalla Characterizing Extravascular Fluid Transport of Macromolecules in the Tumor Interstitium by Magnetic Resonance Imaging Cancer Res., February 15, 2005; 65(4): 1425 - 1432. [Abstract] [Full Text] [PDF]
|
|